Table 3.
Variable | n a | Hazard ratio (HR) | 95 % Confidence interval (CI) | p |
---|---|---|---|---|
Age | ||||
≤60 years | 78 | – | – | – |
>60 years | 96 | 1.37 | 0.78–2.42 | 0.267 |
Gender | ||||
Male | 102 | – | – | – |
Female | 72 | 1.00 | 0.60–1.66 | 0.976 |
Depth of invasion | ||||
Serosa-negative | 23 | – | – | – |
Serosa-positive | 151 | 1.21 | 0.34–4.24 | 0.759 |
Nodal status | ||||
Node-negative | 45 | – | – | – |
Node-positive | 129 | 1.49 | 0.31–6.98 | 0.610 |
TNM stage | ||||
II | 57 | – | – | – |
IIIA | 68 | 1.69 | 0.38–7.39 | 0.484 |
IIIB | 29 | 4.05 | 0.79–20.57 | 0.091 |
IV M0 | 20 | 5.50 | 1.08–27.93 | 0.040 |
Location | ||||
Stomach | 147 | – | – | – |
EGJ | 27 | 1.76 | 0.90–3.44 | 0.094 |
Laurén histology | ||||
Intestinal-type | 107 | – | – | – |
Diffuse-type | 59 | 1.29 | 0.75–2.23 | 0.354 |
Mixed-type | 8 | 0.73 | 0.21–2.44 | 0.612 |
Adjuvant therapy | ||||
Resection alone | 72 | – | – | – |
Chemoradiotherapy | 102 | 0.46 | 0.26–0.82 | 0.008 |
aA total of 174 patients and 66 events (deaths) were considered in the multivariate analysis